Lombard Odier Asset Management (Switzerland)’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-348,196
Closed -$1.72M 160
2021
Q4
$1.72M Buy
348,196
+29,451
+9% +$171K 0.11% 103
2021
Q3
$2.14M Buy
318,745
+29,586
+10% +$212K 0.13% 100
2021
Q2
$2.29M Buy
+289,159
New +$2M 0.12% 116

Other funds holding ACIU

Lombard Odier Asset Management (Switzerland)'s ACIU Position: Q1 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of AC Immune (ACIU) in Q1 2022, closing a stake of 348,196 shares — an estimated $1.72M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in ACIU in Q2 2021 and held it in 3 quarters. The position peaked at $2.29M in Q2 2021. 36 funds tracked by Wall St. Rank hold ACIU as of Q1 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining AC Immune position as of Q1 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 348,196 AC Immune shares in Q1 2022, an estimated $1.72M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in AC Immune in Q2 2021 and held it in 3 quarters.
  • Lombard Odier Asset Management (Switzerland)'s AC Immune position peaked at $2.29M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held AC Immune as of Q1 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.